Nicholas Delaney, MD
Orthopaedic Surgery · Albany, NYNPI 1558596114
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (48.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Seapearl East, Inc accounts for 73.6% of it on its own, with 14 other manufacturers making up the rest.
Across 60 payments — averaging $134.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seapearl East, Inc$6K
- Arthrex$1K
- Johnson & Johnson$396
- Stryker$202
- Zimmer Biomet$150
- ERMI LLC$41
- plus $224 from 9 others
Across 4 payments — averaging $5609.90 each. An ownership or investment interest held by the physician or an immediate family member.
- Lazurite Inc.$22K
What the payments were for
- Travel & lodging$2,22328%
- Food & beverage$1,93124%
- Education$3,91649%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seapearl East, Inc | 16 | $5,942 |
| Arthrex | 15 | $1,114 |
| Johnson & Johnson | 11 | $396 |
| Stryker | 2 | $202 |
| Zimmer Biomet | 2 | $150 |
| ERMI LLC | 1 | $41 |
| Electronic Waveform Lab, Inc. | 2 | $40 |
| Fidia Pharma USA Inc. | 2 | $35 |
| Sanofi-aventis U.S. LLC | 2 | $29 |
| Amgen | 2 | $27 |
| Ossur Americas, Inc. | 1 | $24 |
| Avanos Medical | 1 | $21 |
| Orthogenrx Inc. | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| Vertos Medical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,070 in reported general payments places this provider in the 60th percentile of 1,079 orthopaedic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 40 | $106 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Albany
- Andrew RosenbaumAlbany$467K
- Anthony RomeoNew York$26.8M
- Lawrence LenkeNew York$26.8M
- Edwin SuNew York$13.2M
- William RicciNew York$11.6M
- Steven HaasNew York$11.3M
- Giles ScuderiNew York$10.7M
- Joseph ZuckermanNew York$9.9M
- Evan FlatowNew York$9.6M
- Bradford ParsonsNew York$9.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.